Compliance with drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne
Completed
- Conditions
- Mild to moderate acneSkin and Connective Tissue Diseases
- Registration Number
- ISRCTN14257026
- Lead Sponsor
- Isdin SA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Mild to moderate acne necessitating topical treatments with retinoid or antibiotics
Exclusion Criteria
Severe acne
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the impact of adherence and compliance to the treatments on the clinical outcome in patients with mild to moderate acne.
- Secondary Outcome Measures
Name Time Method Evaluation of the impact of the use of specific adjuvant treatments (facial cleansing, emollient moisturizing and lenitive specific topical products) on adherence level and entity of the clinical outcome obtained. <br><br>Acne severity was assessed at each visit with a 5-point score system (from 0 to 4), absolute count of lesions and percentage of patient reaching a =50% reduction in lesion numbers.<br><br> Adherence and Compliance were evaluated at visit 2 and visit 3 by means of validated 4-item questionnaire (ECOB) with a dichotomous classification: good adherence/compliance (ECOB score 4) and poor adherence/compliance (ECOB score <4). Poor compliance to treatment was defined as a different to expected answer on the ECOB questionnaire.a negative answer to question number 2 or number 3 of ECOB questionnaire.